MedPath

Spinal Restoration, Inc.

Spinal Restoration, Inc. logo
🇺🇸United States
Ownership
Private
Established
2004-01-01
Employees
11
Market Cap
-
Website
http://www.spinalrestoration.com

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 3:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 3
1 (50.0%)

Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® System

Phase 3
Terminated
Conditions
Back Pain
Chronic Low Back Pain
Internal Disc Disruption
Degenerative Disc Disease
Interventions
Biological: BIOSTAT BIOLOGX
Drug: Saline
First Posted Date
2009-11-11
Last Posted Date
2014-05-16
Lead Sponsor
Spinal Restoration, Inc.
Target Recruit Count
220
Registration Number
NCT01011816
Locations
🇺🇸

Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, United States

🇺🇸

HOPE Research Institute, Phoenix, Arizona, United States

🇺🇸

Pain Control Associates of San Diego, Chula Vista, California, United States

and more 17 locations

Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® Disc Augmentation System: A Pilot Study

Not Applicable
Completed
Conditions
Low Back Pain
First Posted Date
2008-06-09
Last Posted Date
2015-06-22
Lead Sponsor
Spinal Restoration, Inc.
Target Recruit Count
15
Registration Number
NCT00693784

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.